Dienogest, a synthetic progestin widely used for the treatment of endometriosis, exhibits its therapeutic effects by inhibiting ovulation, and selectively blocking the activity of cyclooxygenase-2 (COX-2), thus inhibiting inflammation. The gene discussed is PTGS2; the disease is endometriosis.